Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

The use of pressure-relieving devices (beds, mattresses and overlays) for the prevention of pressure ulcers in primary and secondary care.

BIBLIOGRAPHIC SOURCE(S)

  • National Collaborating Centre for Nursing and Supportive Care. The use of pressure-relieving devices (beds, mattresses and overlays) for the prevention of pressure ulcers in primary and secondary care. London (UK): National Institute for Clinical Excellence (NICE); 2003 Oct. 126 p.

GUIDELINE STATUS

This is the current release of the guideline.

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

Evidence categories (I-IV) and recommendation grades (A-D and 1-3) are defined at the end of the Major Recommendations field.

Risk Assessment and Prevention

Identifying Individuals Vulnerable to or at Elevated Risk of Pressure Ulcers

3 - Assessing an individual's risk of developing pressure ulcers should involve both informal and formal assessment procedures.

3 - Risk assessment should be carried out by personnel who have undergone appropriate training to recognise the risk factors that contribute to the development of pressure ulcers and know how to initiate and maintain correct and suitable preventative measures.

3 - The timing of risk assessment should be based on each individual case. However, it should take place within 6 hours of the start of admission to the episode of care.

3 - If an individual is considered not to be vulnerable to or at elevated risk of pressure ulcers on initial assessment, reassessment should occur if there is a change in an individual's condition that increases risk (see recommendations under "Risk Factors" below).

3 - All formal assessments of risk should be documented/recorded and made accessible to all members of the interdisciplinary team.

Use of Risk Assessment Tools

1 - Risk assessment tools should only be used as an aide memoire and should not replace clinical judgment.

If use of a risk assessment tool is preferred (to assist clinical judgment), it is recommended that a scale that has been tested for use in the same specialty is chosen.

Risk Factors

2 - An individual's potential to develop pressure ulcers may be influenced by the following intrinsic risk factors, which therefore should be considered when performing a risk assessment:

  • Reduced mobility or immobility
  • Sensory impairment
  • Acute illness
  • Level of consciousness
  • Extremes of age
  • Vascular disease
  • Severe chronic or terminal illness
  • Previous history of pressure damage
  • Malnutrition and dehydration

2 - The following extrinsic risk factors are involved in tissue damage and should be removed or diminished to prevent injury: pressure, shearing, and friction.

2 - The potential of an individual to develop pressure ulcers may be exacerbated by the following factors, which therefore should be considered when performing a risk assessment: medication and moisture to the skin.

Patient Factors to Consider in Selecting Pressure-relieving Device

D - Decisions about which pressure-relieving device to use should be based on cost considerations and an overall assessment of the individual. Holistic assessment should include all of the following and should not be based solely on scores from risk assessment tools:

  • Identified levels of risk
  • Skin assessment
  • Comfort
  • General health state
  • Lifestyle and abilities
  • Critical care needs
  • Acceptability of the proposed pressure-relieving equipment to the patient and/or carer

Provision for All Individuals Vulnerable to Pressure Ulcers

B - All individuals assessed as being vulnerable to pressure ulcers should, as a minimum provision, be placed on a high-specification foam mattress with pressure-relieving properties

Patients at Elevated Risk of Developing Pressure Ulcers

D - Although there is no research evidence that high-tech pressure relieving mattresses and overlays are more effective than high-specification (low-tech) foam mattresses and overlays, professional consensus recommends that consideration should be given to the use of alternating pressure or other high-tech pressure-relieving systems:

  • As a first-line preventative strategy for people at elevated risk as identified by holistic assessment
  • When the individual's previous history of pressure ulcer prevention and/or clinical condition indicates that he or she is best cared for on a high-tech device
  • When a low-tech device has failed

Patients Undergoing Surgery

D - All individuals undergoing surgery and assessed as being vulnerable to pressure ulcers should, as a minimum provision, be placed on either a high-specification foam theatre mattress or other pressure-redistributing surface.

Repositioning and 24-hour Approach to Provision of Pressure-Relieving Devices

D - The provision of pressure-relieving devices needs a 24- hour approach. It should include consideration of all surfaces used by the patient

D - Support surface and positioning needs should be assessed and reviewed regularly and determined by results of skin inspection, patient comfort, ability, and general state. Thus repositioning should occur when individuals are on pressure relieving devices

D - The management of a patient in a sitting position is also important. Even with appropriate pressure relief, it may be necessary to restrict sitting time to less then 2 hours until the condition of an individual with elevated risk changes

Coordinated Time Specified Approach

D - A pressure ulcer reduction strategy should incorporate a coordinated approach to the acquisition, allocation, and management of pressure-relieving equipment. The time elapsing between assessment and use of the device should be specified in this strategy.

Education and Information-giving

D - All healthcare professionals should be educated about:

  • Pressure ulcer risk assessment and prevention
  • Selection, use, and maintenance of pressure-relieving devices
  • Patient education and information giving

D - Individuals vulnerable to or at elevated risk of developing pressure ulcers and their carers should be informed verbally and in writing about:

  • The prevention of pressure ulcers using pressure-relieving strategies
  • The use and maintenance of pressure-relieving devices
  • Where they can seek further advice and assistance

Definitions:

Evidence Categories

I: Evidence from:

  • meta-analysis of randomised controlled trials, or
  • at least one randomised controlled trial

II: Evidence from:

  • at least one controlled study without randomisation, or
  • at least one other type of quasi-experimental study

III: Evidence from non-experimental descriptive studies, such as comparative studies, correlation studies and case-control studies

IV: Evidence from expert committee reports or opinions and/or clinical experience of respected authorities

Recommendation Grades

A: Directly based on category I evidence

B: Directly based on:

  • category II evidence, or
  • extrapolated recommendation from category I evidence

C: Directly based on:

  • category III evidence, or
  • extrapolated recommendation from category I or II evidence

D: Directly based on:

  • category IV evidence
  • extrapolated recommendation from category I, II, or III evidence

Grading Scheme

Evidence

1: Generally consistent finding in a majority of multiple acceptable studies

2: Either based on a single acceptable study, or a weak or inconsistent finding in multiple acceptable studies

3: Limited scientific evidence that does not meet all the criteria of acceptable studies or absence of directly applicable studies of good quality. This includes expert opinion.

CLINICAL ALGORITHM(S)

Algorithms are provided in the original guideline document for pressure ulcer risk assessment and prevention.

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The type of supporting evidence is identified and graded for each recommendation (see "Major Recommendations").

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

  • National Collaborating Centre for Nursing and Supportive Care. The use of pressure-relieving devices (beds, mattresses and overlays) for the prevention of pressure ulcers in primary and secondary care. London (UK): National Institute for Clinical Excellence (NICE); 2003 Oct. 126 p.

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

2003 Oct

GUIDELINE DEVELOPER(S)

National Collaborating Centre for Nursing and Supportive Care - National Government Agency [Non-U.S.]

SOURCE(S) OF FUNDING

National Institute for Clinical Excellence (NICE)

GUIDELINE COMMITTEE

Guideline Development Groups

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Guideline Developers: Ms Jo Rycroft-Malone, Project Officer (RCN Institute); Ms Elizabeth McInnes, Formerly Project Officer RCN Institute

Expert Consensus Group Members: Ms Maureen Benbow, Tissue Viability Nurse, Leighton Hospital; Dr Mary R. Bliss, Consultant Geriatrician, Bryning Day Hospital; Dr Michael Clark, Senior Research Fellow, University of Wales College of Medicine, Cardiff; Ms Linda Clarke, Patient Services Manager, Spinal Injuries Association, London; Mrs Carol Dealey, Research Fellow, University Hospital Birmingham NHS Trust; Dr Krzysztof Gebhardt, Clinical Nurse Specialist for Pressure Sore Prevention, St Georges Hospital, London; Ms Deborah Hofman, Clinical Nurse Specialist, Wound Healing Unit, The Churchill Hospital, Oxford; Ms Pennie Roberts, Head of Physiotherapy Studies, Leeds Metropolitan University; Dr Shyam Rithalia, Senior Lecturer, University of Salford; Professor John Young; Consultant Geriatrician St Lukes Hospital, Bradford

Pressure-relieving Devices Group Members: Dr Paul Yerrell (Group Leader) Oxford Brookes University; Mr Malcolm Blanch, Carers UK; Dr Michael Clark, Wound Healing Research Unit, University of Wales College of Medicine; Mr Mark Collier, United Lincolnshire Hospitals NHS Trust; Mr Louis Hecht, Tissue Viability Society; Mr Nick Malone, Oxford Radcliffe Trust; Dr Jed Rowe, Royal College of Physicians; Dr Eileen Scott, North Tees & Hartlepool NHS Trust; Mrs Fiona Stephens, Royal College of Nursing (now East Kent PCTs); Mr Adam Thomas, RADAR; Dr Elizabeth White, College of Occupational Therapists

National Collaborating Centre for Nursing and Supportive Care Members: Ms Sue Boyt, Administrator; Dr Gill Harvey, Director; Ms Rosa Legood, Health Economist (seconded from Health Economics Research Centre, University of Oxford); Ms Elizabeth McInnes, Senior R&D Fellow; Mr Robin Snowball, Information Scientist (seconded from Cairns Library, John Radcliffe Hospital, Oxford); Mr Edward Weir, Centre Manager

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

All members of the guideline development group (GDG) were required to make formal declarations of interest at the outset, which were recorded. GDG members were also asked to declare interests at the beginning of each GDG meeting. This information is recorded in the meeting minutes and kept on file at the National Collaborating Centre for Nursing and Supportive Care (NCC-NSC).

GUIDELINE STATUS

This is the current release of the guideline.

GUIDELINE AVAILABILITY

Electronic copies: Available in Portable Document Format (PDF) format from the National Institute for Clinical Excellence (NICE) Web site.

Print copies: Available from the National Health Service (NHS) Response Line 0870 1555 455, ref: N0330. 11 Strand, London, WC2N 5HR.

AVAILABILITY OF COMPANION DOCUMENTS

The following are available:

Print copies: Available from the National Health Service (NHS) Response Line 0870 1555 455. 11 Strand, London, WC2N 5HR.

Additionally, Audit Criteria can be found in Section 8 of the original guideline document.

PATIENT RESOURCES

The following is available:

  • Pressure ulcers - prevention and treatment. Understanding NICE guidance - information for people with pressure ulcers (also known as pressure sores or bed sores) and those at risk of developing pressure ulcers, their families and carers, and the public. National Institute for Health and Clinical Excellence (NICE), 2005 Sep. 18 p.

Electronic copies: Available from the National Institute for Clinical Excellence (NICE) Web site.

Print copies: Available from the National Health Service (NHS), 11 Strand, London, WC2N 5HR. Response Line 0870 1555 455, ref N0479.

Please note: This patient information is intended to provide health professionals with information to share with their patients to help them better understand their health and their diagnosed disorders. By providing access to this patient information, it is not the intention of NGC to provide specific medical advice for particular patients. Rather we urge patients and their representatives to review this material and then to consult with a licensed health professional for evaluation of treatment options suitable for them as well as for diagnosis and answers to their personal medical questions. This patient information has been derived and prepared from a guideline for health care professionals included on NGC by the authors or publishers of that original guideline. The patient information is not reviewed by NGC to establish whether or not it accurately reflects the original guideline's content.

NGC STATUS

This NGC summary was completed by ECRI on July 13, 2004. The information was verified by the guideline developer on November 26, 2004.

COPYRIGHT STATEMENT

This summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo